Skip to main content

MeiraGTx Holdings plc

MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001735438

In the last 90 days, MeiraGTx Holdings plc insiders filed 0 open-market purchases and 3 sales; 158 institutions reported holding it in 13F filings for Q2 2026, worth $1.07B in total; no superinvestor holds it.

Holders of 5% or more of MGTX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of MeiraGTx Holdings plc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MGTX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Prosight Management, LP13G/A5.40%4.36M shares–May 14, 20251 filingMay 14, 2025SEC
Adage Capital Management, L.P.13G/A5.20%4.18M shares–Nov 13, 20251 filingNov 13, 2025SEC
Adena Estate Inc.13G5.10%3.27M sharesNewFeb 9, 20241 filingFeb 9, 2024SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

3 Schedule 13D and 13G filings on MeiraGTx Holdings plc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MGTX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 13, 20259:05 AM ETAdage Capital Management, L.P.and 2 others13G/A5.20%4.18M shares–Sep 30, 2025SEC
May 14, 20258:30 AM ETProsight Management, LPand 4 others13G/A5.40%4.36M shares–Mar 31, 2025SEC
Feb 9, 202410:10 AM ETAdena Estate Inc.13G5.10%3.27M sharesNewDec 31, 2023SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell MeiraGTx Holdings plc shares.

No Form 144 notices for MeiraGTx Holdings plc are on file.